(Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary ...
Zacks Investment Research on MSN
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
IDEXX Laboratories IDXX has shown remarkable momentum so far this year, climbing 52.9%. The stock has comfortably surpassed the industry’s 12.9% fall and the S&P 500 Composite’s 13.8% gain. Carrying a ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a leader in veterinary diagnostics and software, has been navigating a complex market landscape characterized by fluctuating veterinary visit trends and ...
Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention "Building on over 40 years of IDEXX's ...
HENDERSON, Nev., Jan. 12, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the availability of its Nu.Q® Vet Cancer Test ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback